Immuneering’s treatment of pancreatic cancer was granted FDA orphan designation, according to a post to the agency’s website.
Don't Miss our Black Friday Offers:
- Unlock your investing potential with TipRanks Premium - Now At 40% OFF!
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter